We updated our research report on HCP, Inc. (HCP - Free Report) on Aug 26, 2016. This Irvine, CA-based healthcare real estate investment trust (“REIT”) is engaged in acquiring, developing, managing, selling and leasing a diverse portfolio of healthcare real estate related properties.
HCP is banking on accretive acquisitions with solid, risk-adjusted returns to keep its growth momentum going. For the full year 2015, the company made total investments worth $2.1 billion with the trend continuing in 2016. In fact, during the second quarter and through Aug 8, the company declared investment transactions to the tune of $111 million, taking the year to date investments to $475 million. These investments offer a solid growth platform for HCP.
In addition, HCP has one of the most diversified, high-quality and well-balanced portfolios in the healthcare sector with exposure to all types of facilities. The diverse product mix of the company allows it to explore the opportunities available in various areas. Further, aging population, long-term leases, decent cash-flows and strong dividend payments augur well for the company.
On Aug 9, HCP reported second-quarter 2016 adjusted funds from operations (“FFO”) per share of 74 cents, beating the Zacks Consensus Estimate of 70 cents. Results were driven by better-than-expected growth in revenues.
The stock presently carries a Zacks Rank #2 (Buy).
Investors interested in the REIT sector can consider other favorably ranked stocks like Alexandria Real Estate Equities, Inc. (ARE - Free Report) , Arbor Realty Trust Inc. (ABR - Free Report) and CareTrust REIT, Inc. (CTRE - Free Report) . All these stocks hold the same Zacks Rank as HCP.
Note: All EPS numbers presented in this write-up represent funds from operations (“FFO”) per share. FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
We updated our research report on HCP, Inc. (HCP - Free Report) on Aug 26, 2016. This Irvine, CA-based healthcare real estate investment trust (“REIT”) is engaged in acquiring, developing, managing, selling and leasing a diverse portfolio of healthcare real estate related properties.
HCP is banking on accretive acquisitions with solid, risk-adjusted returns to keep its growth momentum going. For the full year 2015, the company made total investments worth $2.1 billion with the trend continuing in 2016. In fact, during the second quarter and through Aug 8, the company declared investment transactions to the tune of $111 million, taking the year to date investments to $475 million. These investments offer a solid growth platform for HCP.
In addition, HCP has one of the most diversified, high-quality and well-balanced portfolios in the healthcare sector with exposure to all types of facilities. The diverse product mix of the company allows it to explore the opportunities available in various areas. Further, aging population, long-term leases, decent cash-flows and strong dividend payments augur well for the company.
On Aug 9, HCP reported second-quarter 2016 adjusted funds from operations (“FFO”) per share of 74 cents, beating the Zacks Consensus Estimate of 70 cents. Results were driven by better-than-expected growth in revenues.
The stock presently carries a Zacks Rank #2 (Buy).
Investors interested in the REIT sector can consider other favorably ranked stocks like Alexandria Real Estate Equities, Inc. (ARE - Free Report) , Arbor Realty Trust Inc. (ABR - Free Report) and CareTrust REIT, Inc. (CTRE - Free Report) . All these stocks hold the same Zacks Rank as HCP.
Note: All EPS numbers presented in this write-up represent funds from operations (“FFO”) per share. FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on HCP - FREE
Get the latest research report on ARE - FREE
Get the latest research report on ABR - FREE
Get the latest research report on CTRE - FREE